Summary

The global Pemetrexed Disodium for Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Pemetrexed Disodium for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pemetrexed Disodium for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pemetrexed Disodium for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pemetrexed Disodium for Injection players cover Lilly, Amneal Pharmaceuticals, APOTEX, Fresenius Kabi, Sandoz, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Pemetrexed Disodium for Injection Industry Forecast” looks at past sales and reviews total world Pemetrexed Disodium for Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Pemetrexed Disodium for Injection sales for 2025 through 2031. With Pemetrexed Disodium for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pemetrexed Disodium for Injection industry.
This Insight Report provides a comprehensive analysis of the global Pemetrexed Disodium for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pemetrexed Disodium for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pemetrexed Disodium for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pemetrexed Disodium for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pemetrexed Disodium for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Pemetrexed Disodium for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
100mg/Pcs
500mg/Pcs
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Lilly
Amneal Pharmaceuticals
APOTEX
Fresenius Kabi
Sandoz
Baxter
Biocon
Waverley Pharma
Accord Healthcare
Pfizer (Hospira)
Dr. Reddy's Laboratories
Nang Kuang Pharmaceutical
Eugia Pharma
Zydus Lifesciences
Jiangsu Hansoh Pharmaceutical
Qilu Pharmaceutical
Sichuan Huiyu Pharmaceutical
Kelun Pharmaceutical
Yangtze River Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Zhendong Group
Lianyungang Jaripharm Pharmaceutical
Jiangsu Simcere Pharmaceutical
Suzhou Erye Pharmaceutical
Shanghai Chemo Wanbang Biopharma
Hainan Jinrui Pharmaceutical
Dezhou Deyao Pharmaceutical
Nanjing Pharmaceutical Factory
Beijing Xiehe Pharmaceutical
Suzhou Thery Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pemetrexed Disodium for Injection market?
What factors are driving Pemetrexed Disodium for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pemetrexed Disodium for Injection market opportunities vary by end market size?
How does Pemetrexed Disodium for Injection break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pemetrexed Disodium for Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pemetrexed Disodium for Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pemetrexed Disodium for Injection by Country/Region, 2020, 2024 & 2031
2.2 Pemetrexed Disodium for Injection Segment by Type
2.2.1 100mg/Pcs
2.2.2 500mg/Pcs
2.3 Pemetrexed Disodium for Injection Sales by Type
2.3.1 Global Pemetrexed Disodium for Injection Sales Market Share by Type (2020-2025)
2.3.2 Global Pemetrexed Disodium for Injection Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pemetrexed Disodium for Injection Sale Price by Type (2020-2025)
2.4 Pemetrexed Disodium for Injection Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Pemetrexed Disodium for Injection Sales by Application
2.5.1 Global Pemetrexed Disodium for Injection Sale Market Share by Application (2020-2025)
2.5.2 Global Pemetrexed Disodium for Injection Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pemetrexed Disodium for Injection Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pemetrexed Disodium for Injection Breakdown Data by Company
3.1.1 Global Pemetrexed Disodium for Injection Annual Sales by Company (2020-2025)
3.1.2 Global Pemetrexed Disodium for Injection Sales Market Share by Company (2020-2025)
3.2 Global Pemetrexed Disodium for Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Pemetrexed Disodium for Injection Revenue by Company (2020-2025)
3.2.2 Global Pemetrexed Disodium for Injection Revenue Market Share by Company (2020-2025)
3.3 Global Pemetrexed Disodium for Injection Sale Price by Company
3.4 Key Manufacturers Pemetrexed Disodium for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pemetrexed Disodium for Injection Product Location Distribution
3.4.2 Players Pemetrexed Disodium for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pemetrexed Disodium for Injection by Geographic Region
4.1 World Historic Pemetrexed Disodium for Injection Market Size by Geographic Region (2020-2025)
4.1.1 Global Pemetrexed Disodium for Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pemetrexed Disodium for Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pemetrexed Disodium for Injection Market Size by Country/Region (2020-2025)
4.2.1 Global Pemetrexed Disodium for Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pemetrexed Disodium for Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pemetrexed Disodium for Injection Sales Growth
4.4 APAC Pemetrexed Disodium for Injection Sales Growth
4.5 Europe Pemetrexed Disodium for Injection Sales Growth
4.6 Middle East & Africa Pemetrexed Disodium for Injection Sales Growth
5 Americas
5.1 Americas Pemetrexed Disodium for Injection Sales by Country
5.1.1 Americas Pemetrexed Disodium for Injection Sales by Country (2020-2025)
5.1.2 Americas Pemetrexed Disodium for Injection Revenue by Country (2020-2025)
5.2 Americas Pemetrexed Disodium for Injection Sales by Type (2020-2025)
5.3 Americas Pemetrexed Disodium for Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pemetrexed Disodium for Injection Sales by Region
6.1.1 APAC Pemetrexed Disodium for Injection Sales by Region (2020-2025)
6.1.2 APAC Pemetrexed Disodium for Injection Revenue by Region (2020-2025)
6.2 APAC Pemetrexed Disodium for Injection Sales by Type (2020-2025)
6.3 APAC Pemetrexed Disodium for Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pemetrexed Disodium for Injection by Country
7.1.1 Europe Pemetrexed Disodium for Injection Sales by Country (2020-2025)
7.1.2 Europe Pemetrexed Disodium for Injection Revenue by Country (2020-2025)
7.2 Europe Pemetrexed Disodium for Injection Sales by Type (2020-2025)
7.3 Europe Pemetrexed Disodium for Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pemetrexed Disodium for Injection by Country
8.1.1 Middle East & Africa Pemetrexed Disodium for Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pemetrexed Disodium for Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Pemetrexed Disodium for Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Pemetrexed Disodium for Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pemetrexed Disodium for Injection
10.3 Manufacturing Process Analysis of Pemetrexed Disodium for Injection
10.4 Industry Chain Structure of Pemetrexed Disodium for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pemetrexed Disodium for Injection Distributors
11.3 Pemetrexed Disodium for Injection Customer
12 World Forecast Review for Pemetrexed Disodium for Injection by Geographic Region
12.1 Global Pemetrexed Disodium for Injection Market Size Forecast by Region
12.1.1 Global Pemetrexed Disodium for Injection Forecast by Region (2026-2031)
12.1.2 Global Pemetrexed Disodium for Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pemetrexed Disodium for Injection Forecast by Type (2026-2031)
12.7 Global Pemetrexed Disodium for Injection Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Lilly
13.1.1 Lilly Company Information
13.1.2 Lilly Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.1.3 Lilly Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Lilly Main Business Overview
13.1.5 Lilly Latest Developments
13.2 Amneal Pharmaceuticals
13.2.1 Amneal Pharmaceuticals Company Information
13.2.2 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.2.3 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Amneal Pharmaceuticals Main Business Overview
13.2.5 Amneal Pharmaceuticals Latest Developments
13.3 APOTEX
13.3.1 APOTEX Company Information
13.3.2 APOTEX Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.3.3 APOTEX Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 APOTEX Main Business Overview
13.3.5 APOTEX Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.4.3 Fresenius Kabi Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Sandoz
13.5.1 Sandoz Company Information
13.5.2 Sandoz Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.5.3 Sandoz Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sandoz Main Business Overview
13.5.5 Sandoz Latest Developments
13.6 Baxter
13.6.1 Baxter Company Information
13.6.2 Baxter Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.6.3 Baxter Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Baxter Main Business Overview
13.6.5 Baxter Latest Developments
13.7 Biocon
13.7.1 Biocon Company Information
13.7.2 Biocon Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.7.3 Biocon Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Biocon Main Business Overview
13.7.5 Biocon Latest Developments
13.8 Waverley Pharma
13.8.1 Waverley Pharma Company Information
13.8.2 Waverley Pharma Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.8.3 Waverley Pharma Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Waverley Pharma Main Business Overview
13.8.5 Waverley Pharma Latest Developments
13.9 Accord Healthcare
13.9.1 Accord Healthcare Company Information
13.9.2 Accord Healthcare Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.9.3 Accord Healthcare Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Accord Healthcare Main Business Overview
13.9.5 Accord Healthcare Latest Developments
13.10 Pfizer (Hospira)
13.10.1 Pfizer (Hospira) Company Information
13.10.2 Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.10.3 Pfizer (Hospira) Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Pfizer (Hospira) Main Business Overview
13.10.5 Pfizer (Hospira) Latest Developments
13.11 Dr. Reddy's Laboratories
13.11.1 Dr. Reddy's Laboratories Company Information
13.11.2 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.11.3 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Dr. Reddy's Laboratories Main Business Overview
13.11.5 Dr. Reddy's Laboratories Latest Developments
13.12 Nang Kuang Pharmaceutical
13.12.1 Nang Kuang Pharmaceutical Company Information
13.12.2 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.12.3 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Nang Kuang Pharmaceutical Main Business Overview
13.12.5 Nang Kuang Pharmaceutical Latest Developments
13.13 Eugia Pharma
13.13.1 Eugia Pharma Company Information
13.13.2 Eugia Pharma Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.13.3 Eugia Pharma Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Eugia Pharma Main Business Overview
13.13.5 Eugia Pharma Latest Developments
13.14 Zydus Lifesciences
13.14.1 Zydus Lifesciences Company Information
13.14.2 Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.14.3 Zydus Lifesciences Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Zydus Lifesciences Main Business Overview
13.14.5 Zydus Lifesciences Latest Developments
13.15 Jiangsu Hansoh Pharmaceutical
13.15.1 Jiangsu Hansoh Pharmaceutical Company Information
13.15.2 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.15.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Jiangsu Hansoh Pharmaceutical Main Business Overview
13.15.5 Jiangsu Hansoh Pharmaceutical Latest Developments
13.16 Qilu Pharmaceutical
13.16.1 Qilu Pharmaceutical Company Information
13.16.2 Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.16.3 Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Qilu Pharmaceutical Main Business Overview
13.16.5 Qilu Pharmaceutical Latest Developments
13.17 Sichuan Huiyu Pharmaceutical
13.17.1 Sichuan Huiyu Pharmaceutical Company Information
13.17.2 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.17.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Sichuan Huiyu Pharmaceutical Main Business Overview
13.17.5 Sichuan Huiyu Pharmaceutical Latest Developments
13.18 Kelun Pharmaceutical
13.18.1 Kelun Pharmaceutical Company Information
13.18.2 Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.18.3 Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Kelun Pharmaceutical Main Business Overview
13.18.5 Kelun Pharmaceutical Latest Developments
13.19 Yangtze River Pharmaceutical Group
13.19.1 Yangtze River Pharmaceutical Group Company Information
13.19.2 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.19.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Yangtze River Pharmaceutical Group Main Business Overview
13.19.5 Yangtze River Pharmaceutical Group Latest Developments
13.20 Jiangsu Aosaikang Pharmaceutical
13.20.1 Jiangsu Aosaikang Pharmaceutical Company Information
13.20.2 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.20.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview
13.20.5 Jiangsu Aosaikang Pharmaceutical Latest Developments
13.21 Zhendong Group
13.21.1 Zhendong Group Company Information
13.21.2 Zhendong Group Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.21.3 Zhendong Group Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Zhendong Group Main Business Overview
13.21.5 Zhendong Group Latest Developments
13.22 Lianyungang Jaripharm Pharmaceutical
13.22.1 Lianyungang Jaripharm Pharmaceutical Company Information
13.22.2 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.22.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Lianyungang Jaripharm Pharmaceutical Main Business Overview
13.22.5 Lianyungang Jaripharm Pharmaceutical Latest Developments
13.23 Jiangsu Simcere Pharmaceutical
13.23.1 Jiangsu Simcere Pharmaceutical Company Information
13.23.2 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.23.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Jiangsu Simcere Pharmaceutical Main Business Overview
13.23.5 Jiangsu Simcere Pharmaceutical Latest Developments
13.24 Suzhou Erye Pharmaceutical
13.24.1 Suzhou Erye Pharmaceutical Company Information
13.24.2 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.24.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Suzhou Erye Pharmaceutical Main Business Overview
13.24.5 Suzhou Erye Pharmaceutical Latest Developments
13.25 Shanghai Chemo Wanbang Biopharma
13.25.1 Shanghai Chemo Wanbang Biopharma Company Information
13.25.2 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.25.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 Shanghai Chemo Wanbang Biopharma Main Business Overview
13.25.5 Shanghai Chemo Wanbang Biopharma Latest Developments
13.26 Hainan Jinrui Pharmaceutical
13.26.1 Hainan Jinrui Pharmaceutical Company Information
13.26.2 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.26.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.26.4 Hainan Jinrui Pharmaceutical Main Business Overview
13.26.5 Hainan Jinrui Pharmaceutical Latest Developments
13.27 Dezhou Deyao Pharmaceutical
13.27.1 Dezhou Deyao Pharmaceutical Company Information
13.27.2 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.27.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.27.4 Dezhou Deyao Pharmaceutical Main Business Overview
13.27.5 Dezhou Deyao Pharmaceutical Latest Developments
13.28 Nanjing Pharmaceutical Factory
13.28.1 Nanjing Pharmaceutical Factory Company Information
13.28.2 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.28.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.28.4 Nanjing Pharmaceutical Factory Main Business Overview
13.28.5 Nanjing Pharmaceutical Factory Latest Developments
13.29 Beijing Xiehe Pharmaceutical
13.29.1 Beijing Xiehe Pharmaceutical Company Information
13.29.2 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.29.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.29.4 Beijing Xiehe Pharmaceutical Main Business Overview
13.29.5 Beijing Xiehe Pharmaceutical Latest Developments
13.30 Suzhou Thery Pharmaceutical
13.30.1 Suzhou Thery Pharmaceutical Company Information
13.30.2 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
13.30.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.30.4 Suzhou Thery Pharmaceutical Main Business Overview
13.30.5 Suzhou Thery Pharmaceutical Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Pemetrexed Disodium for Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pemetrexed Disodium for Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg/Pcs
Table 4. Major Players of 500mg/Pcs
Table 5. Global Pemetrexed Disodium for Injection Sales by Type (2020-2025) & (K Units)
Table 6. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2020-2025)
Table 7. Global Pemetrexed Disodium for Injection Revenue by Type (2020-2025) & ($ million)
Table 8. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2020-2025)
Table 9. Global Pemetrexed Disodium for Injection Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Pemetrexed Disodium for Injection Sale by Application (2020-2025) & (K Units)
Table 11. Global Pemetrexed Disodium for Injection Sale Market Share by Application (2020-2025)
Table 12. Global Pemetrexed Disodium for Injection Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2020-2025)
Table 14. Global Pemetrexed Disodium for Injection Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Pemetrexed Disodium for Injection Sales by Company (2020-2025) & (K Units)
Table 16. Global Pemetrexed Disodium for Injection Sales Market Share by Company (2020-2025)
Table 17. Global Pemetrexed Disodium for Injection Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pemetrexed Disodium for Injection Revenue Market Share by Company (2020-2025)
Table 19. Global Pemetrexed Disodium for Injection Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Pemetrexed Disodium for Injection Producing Area Distribution and Sales Area
Table 21. Players Pemetrexed Disodium for Injection Products Offered
Table 22. Pemetrexed Disodium for Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pemetrexed Disodium for Injection Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Pemetrexed Disodium for Injection Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pemetrexed Disodium for Injection Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pemetrexed Disodium for Injection Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pemetrexed Disodium for Injection Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Pemetrexed Disodium for Injection Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pemetrexed Disodium for Injection Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pemetrexed Disodium for Injection Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pemetrexed Disodium for Injection Sales by Country (2020-2025) & (K Units)
Table 34. Americas Pemetrexed Disodium for Injection Sales Market Share by Country (2020-2025)
Table 35. Americas Pemetrexed Disodium for Injection Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pemetrexed Disodium for Injection Sales by Type (2020-2025) & (K Units)
Table 37. Americas Pemetrexed Disodium for Injection Sales by Application (2020-2025) & (K Units)
Table 38. APAC Pemetrexed Disodium for Injection Sales by Region (2020-2025) & (K Units)
Table 39. APAC Pemetrexed Disodium for Injection Sales Market Share by Region (2020-2025)
Table 40. APAC Pemetrexed Disodium for Injection Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pemetrexed Disodium for Injection Sales by Type (2020-2025) & (K Units)
Table 42. APAC Pemetrexed Disodium for Injection Sales by Application (2020-2025) & (K Units)
Table 43. Europe Pemetrexed Disodium for Injection Sales by Country (2020-2025) & (K Units)
Table 44. Europe Pemetrexed Disodium for Injection Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pemetrexed Disodium for Injection Sales by Type (2020-2025) & (K Units)
Table 46. Europe Pemetrexed Disodium for Injection Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Pemetrexed Disodium for Injection Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Pemetrexed Disodium for Injection Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pemetrexed Disodium for Injection Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Pemetrexed Disodium for Injection Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pemetrexed Disodium for Injection
Table 52. Key Market Challenges & Risks of Pemetrexed Disodium for Injection
Table 53. Key Industry Trends of Pemetrexed Disodium for Injection
Table 54. Pemetrexed Disodium for Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pemetrexed Disodium for Injection Distributors List
Table 57. Pemetrexed Disodium for Injection Customer List
Table 58. Global Pemetrexed Disodium for Injection Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Pemetrexed Disodium for Injection Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pemetrexed Disodium for Injection Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Pemetrexed Disodium for Injection Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pemetrexed Disodium for Injection Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Pemetrexed Disodium for Injection Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pemetrexed Disodium for Injection Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Pemetrexed Disodium for Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pemetrexed Disodium for Injection Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Pemetrexed Disodium for Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Pemetrexed Disodium for Injection Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Pemetrexed Disodium for Injection Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Pemetrexed Disodium for Injection Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Pemetrexed Disodium for Injection Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Lilly Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Lilly Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 74. Lilly Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Lilly Main Business
Table 76. Lilly Latest Developments
Table 77. Amneal Pharmaceuticals Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 79. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Amneal Pharmaceuticals Main Business
Table 81. Amneal Pharmaceuticals Latest Developments
Table 82. APOTEX Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. APOTEX Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 84. APOTEX Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. APOTEX Main Business
Table 86. APOTEX Latest Developments
Table 87. Fresenius Kabi Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 89. Fresenius Kabi Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Fresenius Kabi Main Business
Table 91. Fresenius Kabi Latest Developments
Table 92. Sandoz Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Sandoz Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 94. Sandoz Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Sandoz Main Business
Table 96. Sandoz Latest Developments
Table 97. Baxter Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Baxter Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 99. Baxter Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Baxter Main Business
Table 101. Baxter Latest Developments
Table 102. Biocon Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Biocon Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 104. Biocon Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Biocon Main Business
Table 106. Biocon Latest Developments
Table 107. Waverley Pharma Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Waverley Pharma Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 109. Waverley Pharma Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Waverley Pharma Main Business
Table 111. Waverley Pharma Latest Developments
Table 112. Accord Healthcare Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Accord Healthcare Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 114. Accord Healthcare Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Accord Healthcare Main Business
Table 116. Accord Healthcare Latest Developments
Table 117. Pfizer (Hospira) Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 119. Pfizer (Hospira) Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Pfizer (Hospira) Main Business
Table 121. Pfizer (Hospira) Latest Developments
Table 122. Dr. Reddy's Laboratories Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 124. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Dr. Reddy's Laboratories Main Business
Table 126. Dr. Reddy's Laboratories Latest Developments
Table 127. Nang Kuang Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 129. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Nang Kuang Pharmaceutical Main Business
Table 131. Nang Kuang Pharmaceutical Latest Developments
Table 132. Eugia Pharma Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Eugia Pharma Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 134. Eugia Pharma Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Eugia Pharma Main Business
Table 136. Eugia Pharma Latest Developments
Table 137. Zydus Lifesciences Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 139. Zydus Lifesciences Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Zydus Lifesciences Main Business
Table 141. Zydus Lifesciences Latest Developments
Table 142. Jiangsu Hansoh Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 144. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 145. Jiangsu Hansoh Pharmaceutical Main Business
Table 146. Jiangsu Hansoh Pharmaceutical Latest Developments
Table 147. Qilu Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 148. Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 149. Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 150. Qilu Pharmaceutical Main Business
Table 151. Qilu Pharmaceutical Latest Developments
Table 152. Sichuan Huiyu Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 153. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 154. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 155. Sichuan Huiyu Pharmaceutical Main Business
Table 156. Sichuan Huiyu Pharmaceutical Latest Developments
Table 157. Kelun Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 158. Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 159. Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 160. Kelun Pharmaceutical Main Business
Table 161. Kelun Pharmaceutical Latest Developments
Table 162. Yangtze River Pharmaceutical Group Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 163. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 164. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 165. Yangtze River Pharmaceutical Group Main Business
Table 166. Yangtze River Pharmaceutical Group Latest Developments
Table 167. Jiangsu Aosaikang Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 168. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 169. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 170. Jiangsu Aosaikang Pharmaceutical Main Business
Table 171. Jiangsu Aosaikang Pharmaceutical Latest Developments
Table 172. Zhendong Group Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 173. Zhendong Group Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 174. Zhendong Group Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 175. Zhendong Group Main Business
Table 176. Zhendong Group Latest Developments
Table 177. Lianyungang Jaripharm Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 178. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 179. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 180. Lianyungang Jaripharm Pharmaceutical Main Business
Table 181. Lianyungang Jaripharm Pharmaceutical Latest Developments
Table 182. Jiangsu Simcere Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 183. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 184. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 185. Jiangsu Simcere Pharmaceutical Main Business
Table 186. Jiangsu Simcere Pharmaceutical Latest Developments
Table 187. Suzhou Erye Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 188. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 189. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 190. Suzhou Erye Pharmaceutical Main Business
Table 191. Suzhou Erye Pharmaceutical Latest Developments
Table 192. Shanghai Chemo Wanbang Biopharma Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 193. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 194. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 195. Shanghai Chemo Wanbang Biopharma Main Business
Table 196. Shanghai Chemo Wanbang Biopharma Latest Developments
Table 197. Hainan Jinrui Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 198. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 199. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 200. Hainan Jinrui Pharmaceutical Main Business
Table 201. Hainan Jinrui Pharmaceutical Latest Developments
Table 202. Dezhou Deyao Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 203. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 204. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 205. Dezhou Deyao Pharmaceutical Main Business
Table 206. Dezhou Deyao Pharmaceutical Latest Developments
Table 207. Nanjing Pharmaceutical Factory Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 208. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 209. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 210. Nanjing Pharmaceutical Factory Main Business
Table 211. Nanjing Pharmaceutical Factory Latest Developments
Table 212. Beijing Xiehe Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 213. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 214. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 215. Beijing Xiehe Pharmaceutical Main Business
Table 216. Beijing Xiehe Pharmaceutical Latest Developments
Table 217. Suzhou Thery Pharmaceutical Basic Information, Pemetrexed Disodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 218. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolios and Specifications
Table 219. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 220. Suzhou Thery Pharmaceutical Main Business
Table 221. Suzhou Thery Pharmaceutical Latest Developments


List of Figures
Figure 1. Picture of Pemetrexed Disodium for Injection
Figure 2. Pemetrexed Disodium for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pemetrexed Disodium for Injection Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pemetrexed Disodium for Injection Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pemetrexed Disodium for Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pemetrexed Disodium for Injection Sales Market Share by Country/Region (2024)
Figure 10. Pemetrexed Disodium for Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg/Pcs
Figure 12. Product Picture of 500mg/Pcs
Figure 13. Global Pemetrexed Disodium for Injection Sales Market Share by Type in 2025
Figure 14. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2020-2025)
Figure 15. Pemetrexed Disodium for Injection Consumed in Hospitals
Figure 16. Global Pemetrexed Disodium for Injection Market: Hospitals (2020-2025) & (K Units)
Figure 17. Pemetrexed Disodium for Injection Consumed in Clinics
Figure 18. Global Pemetrexed Disodium for Injection Market: Clinics (2020-2025) & (K Units)
Figure 19. Pemetrexed Disodium for Injection Consumed in Others
Figure 20. Global Pemetrexed Disodium for Injection Market: Others (2020-2025) & (K Units)
Figure 21. Global Pemetrexed Disodium for Injection Sale Market Share by Application (2024)
Figure 22. Global Pemetrexed Disodium for Injection Revenue Market Share by Application in 2025
Figure 23. Pemetrexed Disodium for Injection Sales by Company in 2025 (K Units)
Figure 24. Global Pemetrexed Disodium for Injection Sales Market Share by Company in 2025
Figure 25. Pemetrexed Disodium for Injection Revenue by Company in 2025 ($ millions)
Figure 26. Global Pemetrexed Disodium for Injection Revenue Market Share by Company in 2025
Figure 27. Global Pemetrexed Disodium for Injection Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Pemetrexed Disodium for Injection Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Pemetrexed Disodium for Injection Sales 2020-2025 (K Units)
Figure 30. Americas Pemetrexed Disodium for Injection Revenue 2020-2025 ($ millions)
Figure 31. APAC Pemetrexed Disodium for Injection Sales 2020-2025 (K Units)
Figure 32. APAC Pemetrexed Disodium for Injection Revenue 2020-2025 ($ millions)
Figure 33. Europe Pemetrexed Disodium for Injection Sales 2020-2025 (K Units)
Figure 34. Europe Pemetrexed Disodium for Injection Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Pemetrexed Disodium for Injection Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Pemetrexed Disodium for Injection Revenue 2020-2025 ($ millions)
Figure 37. Americas Pemetrexed Disodium for Injection Sales Market Share by Country in 2025
Figure 38. Americas Pemetrexed Disodium for Injection Revenue Market Share by Country (2020-2025)
Figure 39. Americas Pemetrexed Disodium for Injection Sales Market Share by Type (2020-2025)
Figure 40. Americas Pemetrexed Disodium for Injection Sales Market Share by Application (2020-2025)
Figure 41. United States Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Pemetrexed Disodium for Injection Sales Market Share by Region in 2025
Figure 46. APAC Pemetrexed Disodium for Injection Revenue Market Share by Region (2020-2025)
Figure 47. APAC Pemetrexed Disodium for Injection Sales Market Share by Type (2020-2025)
Figure 48. APAC Pemetrexed Disodium for Injection Sales Market Share by Application (2020-2025)
Figure 49. China Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 53. India Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Pemetrexed Disodium for Injection Sales Market Share by Country in 2025
Figure 57. Europe Pemetrexed Disodium for Injection Revenue Market Share by Country (2020-2025)
Figure 58. Europe Pemetrexed Disodium for Injection Sales Market Share by Type (2020-2025)
Figure 59. Europe Pemetrexed Disodium for Injection Sales Market Share by Application (2020-2025)
Figure 60. Germany Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 61. France Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Pemetrexed Disodium for Injection Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Pemetrexed Disodium for Injection Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Pemetrexed Disodium for Injection Sales Market Share by Application (2020-2025)
Figure 68. Egypt Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Pemetrexed Disodium for Injection Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pemetrexed Disodium for Injection in 2025
Figure 74. Manufacturing Process Analysis of Pemetrexed Disodium for Injection
Figure 75. Industry Chain Structure of Pemetrexed Disodium for Injection
Figure 76. Channels of Distribution
Figure 77. Global Pemetrexed Disodium for Injection Sales Market Forecast by Region (2026-2031)
Figure 78. Global Pemetrexed Disodium for Injection Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Pemetrexed Disodium for Injection Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Pemetrexed Disodium for Injection Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Pemetrexed Disodium for Injection Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Pemetrexed Disodium for Injection Revenue Market Share Forecast by Application (2026-2031)